These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1482754)

  • 1. Increased lipoprotein(a) concentrations in chronic renal failure.
    Haffner SM; Gruber KK; Aldrete G; Morales PA; Stern MP; Tuttle KR
    J Am Soc Nephrol; 1992 Nov; 3(5):1156-62. PubMed ID: 1482754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early elevation of lipoprotein(a) levels in chronic renal insufficiency.
    De Lima JJ; Maranhão RC; Latrilha Mda C; Diament J; Romão JE; Krieger EM; Pileggi F
    Ren Fail; 1997 Jan; 19(1):145-54. PubMed ID: 9044461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid parameters including Lp(a) in hemodialysis patients.
    Elisaf M; Bairaktari H; Tzallas C; Germanos N; Koulouridis E; Pappas M; Siamopoulos KC; Tsolas O
    Ren Fail; 1994; 16(4):501-9. PubMed ID: 7938758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
    Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Lang U; Reitinger J; Pinter G; Utermann G; Dieplinger H
    J Am Soc Nephrol; 1995 Jul; 6(1):110-20. PubMed ID: 7579063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dyslipidemia in end-stage renal disease.
    Prichard SS
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S315-20. PubMed ID: 12939388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) in chronic renal disease.
    Stenvinkel P; Berglund L
    Miner Electrolyte Metab; 1996; 22(1-3):16-21. PubMed ID: 8676811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein (a) levels in end-stage renal failure and renal transplantation.
    Barbagallo CM; Averna MR; Sparacino V; Galione A; Caputo F; Scafidi V; Amato S; Mancino C; Cefalù AB; Notarbartolo A
    Nephron; 1993; 64(4):560-4. PubMed ID: 8366981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
    Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
    Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
    Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
    Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis.
    Yiğitoğlu MR; Polat MF; Akçay F; Ari Z; Uyanik BS; Ozilgili HM
    Jpn Heart J; 1997 Jan; 38(1):83-9. PubMed ID: 9186284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications.
    Levine DM; Gordon BR
    Am J Kidney Dis; 1995 Jul; 26(1):162-9. PubMed ID: 7611248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD.
    Kandoussi A; Cachera C; Pagniez D; Dracon M; Fruchart JC; Tacquet A
    Kidney Int; 1992 Aug; 42(2):424-5. PubMed ID: 1405325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D; Szprynger K
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) and treatment of chronic renal disease.
    Buggy D; Breathnach A; Keogh B; Cooke T; Feely J
    J Intern Med; 1993 Nov; 234(5):453-5. PubMed ID: 8228788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renal replacement therapy on plasma lipoprotein(a) levels.
    Rosas S; Joffe M; Wolfe M; Brayman K; Rader DJ
    Am J Nephrol; 2008; 28(3):361-5. PubMed ID: 18057868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease.
    Trenkwalder E; Gruber A; König P; Dieplinger H; Kronenberg F
    Kidney Int; 1997 Dec; 52(6):1685-92. PubMed ID: 9407518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.